Work

Abstract CT028: Drug-drug interaction potential of EZH2 inhibitor tazemetostat (TAZ)

Year: 2019

Type: conference-abstract

Source: Clinical Trials

DOI: 10.1158/1538-7445.sabcs18-ct028

Authors: Jennifer E. Amengual, Gary K. Schwartz, Lora Inclan, Abhijeet Kumar, Patricia Robles-Medina, Shahnaz Singh-Kandah, Benjamin Suttle, Melissa Beelen, Daniel Persky

Institutions: Columbia University Irving Medical Center, University of Arizona Cancer Center, Epizyme (United States)

Language: English

Topic: Pharmacogenetics and Drug Metabolism

Subfield: Pharmacology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4244808133

Cites:

Cited by:

Related to: 10